Filing Details
- Accession Number:
- 0001179110-14-017481
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-03 16:34:33
- Reporting Period:
- 2014-12-02
- Filing Date:
- 2014-12-03
- Accepted Time:
- 2014-12-03 16:34:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1274057 | Hospira Inc | HSP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1409138 | J Richard Hoffman | C/O Hospira, Inc. 275 North Field Drive Lake Forest IL 60045 | Cvp, Controller & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-02 | 12,000 | $43.18 | 41,440 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-02 | 12,000 | $60.17 | 29,440 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-12-02 | 9,850 | $22.15 | 39,290 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-02 | 9,850 | $60.51 | 29,440 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Acquisiton | 2014-12-02 | 12,000 | $0.00 | 12,000 | $43.18 |
| Common Stock | Stock Options (Right to buy) | Acquisiton | 2014-12-02 | 9,850 | $0.00 | 9,850 | $22.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-03-05 | No | 4 | M | Direct | |
| 0 | 2016-03-04 | No | 4 | M | Direct |
Footnotes
- Exercise of derivative security exempted pursuant to Rule 16b-3.
- The stock options were granted on March 6, 2008, for an exercise price of $43.180, and vested in three equal installments on March 6, 2009, 2010 and 2011. The stock options expire on March 5, 2015.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.08 to $60.32, inclusive. The reporting person undertakes to provide to the company, any security holder of the company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
- The stock options were granted on March 5, 2009, for an exercise price of $22.150, and vested in three equal installments on March 4, 2010, 2011 and 2012. The stock options expire on March 4, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.08 to $60.79, inclusive. The reporting person undertakes to provide to the company, any security holder of the company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
Billionaire Hedge Funds
